Superoxide, superoxide dismutase and ischemic injury

Current Opinion in Investigational Drugs

Volumn 3, Issue 6, 2002, Pages 886-895

  Salvemini, Daniela ^a   Cuzzocrea, Salvatore ^b  

^a MetaPhore Pharmaceuticals   (United States)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Inflammation; Ischemic injury; Superoxide anions; Superoxide dismutase mimetic

Indexed keywords

3 AMINOBENZAMIDE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CYTOKINE; ELASTASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; M 40401; MANGANESE DERIVATIVE; MANGANESE N,N' ETHYLENEBIS(3 METHOXYSALICYLIDENEAMINE); MANGANESE SALEN CHLORIDE; MANGANESEDICHLORO(3,10,13,20,26 PENTAAZATETRACYCLO[20.3.1.0(4,9).0(14,19)] 1(26),22(23),24 HEXACOSATRIENE); MITOCHONDRIAL ENZYME; NICOTINAMIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN; PADGEM PROTEIN; PEROXYNITRITE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; SC 55858; SCAVENGER; SODIUM CHANNEL; SUPEROXIDE; SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE MIMETIC; TETRABENZOIC ACID PORPHYRIN; UNCLASSIFIED DRUG;

CATALYSIS; CELL DAMAGE; CELL INFILTRATION; DNA STRAND BREAKAGE; ENDOTHELIUM INJURY; ENZYME INACTIVATION; HUMAN; IMMUNOHISTOCHEMISTRY; ISCHEMIA; LIPID PEROXIDATION; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; REPERFUSION INJURY; REVIEW; THROMBOCYTE ACTIVATION; THROMBOSIS; TISSUE INJURY;

ANIMALS; FREE RADICAL SCAVENGERS; HUMANS; ORGANOMETALLIC COMPOUNDS; REPERFUSION INJURY; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 0036628344     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (155)

1. Morpurgo E, Cadrobbi R, Morpurgo M, Rigotti P, Schiavon F, Schiavon O, Caliceti P, Ancona E, Veronese FM: Protective effect of superoxide dismutase and polyethylene glycol-linked superoxide dismutase and polyethylene glycol-linked superoxide dismutase against renal warm ischemia/reperfusion injury. Transplantation (1996) 62:1221-1223.
2. Yoshikawa T, Naito Y, Ueda S, Takahashi S, Oyamada H, Yoneta T, Sugino S, Kondo M: Ischemia-reperfusion injury and free radical involvement in gastric mucosal disorders. Adv Exp Med Biol (1990) 264:401-410.
3. Zimmermann BJ, Arndt H, Kubes P, Kurtel H: Reperfusion injury in the small intestine. In: Pathophysiology of Shock, Sepsis and Organ Failure. Schlag G, Redl H (Eds), Springer-Verlag, Berlin, Germany (1993):322-335.
4. Salvemini D, Riley DP, Lennon PJ, Wang ZQ, Currie MG, Macarthur H, Misko TP: Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intestinal damage. Br J Pharmacol (1999) 127:685-692.
5. Salvemini D, Wang ZQ, Zweier JL, Samouilov A, Macarthur H, Misko TP, Currie MG, Cuzzocrea S, Sikorski JA, Riley DP: A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science (1999) 28:304-306.
6. Cuzzocrea S, Mazzon E, Dugo L, Caputi AP, Aston K, Riley DP, Salvemini D: Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion. Br J Pharmacol (2001) 132:19-29.
7. Goossens DP, Rao VK, Harms BA, Starling JR: Superoxide dismutase and catalase in skin flaps during venous occlusion and reperfusion. Ann Plast Surg (1990) 25:21-25.
8. Ambrosio G, Flaherty JT: Effects of the superoxide radical scavenger superoxide dismutase, and of the hydroxyl radical svavenger mannitol, on reperfusion injury in isolated rabbit hearts. Cardiovasc Drugs Ther (1992) 6:623-632. Recombinant human SOD gave significant protection against reperfusion injury without any additional hydroxyl radical scavenger therapy.
9. Grill HP, Zweier JL, Kuppusamy P, Weisfeldt ML, Flaherty JT: Direct measurement of myocardial free radical generation in an in vivo model: Effects of postischemic reperfusion and treatment with human recombinant superoxide dismutase. J Am Coll Cardiol (1992) 20:1604-1611.
10. McCord JM, Fridovich I: Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem (1969) 244:6049-6055.
11. Reaume AG, Elliott JT, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Beal MF, Brown RH Jr, Scott RW, Snider WD: Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet (1996) 13:43-47.
12. Carlsson LM, Jonsson J, Edlundand T, Marklund SL: Mice lacking Extracellular superoxide dismutase are more sensitive to hyperoxia. Proc Natl Acad Sci USA (1995) 92:6264-6268.
13. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH: Dilated cardiomyopathy and neonatal leathality in mutant mice lacking manganese superoxide dismutase. Nat Genet (1995) 11:376-381.
14. Lebovitz RM, Zhang H, Vogel H, Cartwright J Jr., Dionne L, Lu N, Huang S, Matzuk MM: Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide-deficient mice. Proc Natl Acad Sci USA (1996) 93:9782-9787. SOD-2 knockout mice survive for < 3 weeks with a pathology including severe anemia, basal ganglia and brainstem neuronal degeneration and weakness. Mice > 7-days old have extensive mitochondrial injury within these neurons.
15. Melov S, Coskun P, Patel M, Tuinstra R, Cottrell B, Jun AS, Zastawny TH, Dizdaroglu M, Goodman SI, Huang TT, Miziorko H, Epstein CJ, Wallace DC: Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci USA (1999) 96:846-851.
16. Granger DN, Hollwarth MA, McCord JM: Ischemia reperfusion injury: Role of oxygen-derived free radicals. Acta Physiol Scand (1986) 548: 47-63.
17. Granger DN, Rutili G, McCord JM: Superoxide radicals in feline intestinal ischemia. Gastroenterology (1981) 81:22-29.
18. Fantone JC, Ward PA: A review: Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol (1982) 107:395-418.
19. Bittermann H, Aoki N, Lefer AM: Anti-shock effects of human superoxide dismutase in splanchnic occlusion shock. Proc Soc Exp Biol Med (1988) 188:256-271.
20. Krall , Bagley AC, Mullenbach GT, Hallewell RA, Lynch RE: Superoxide mediates the toxicity of paraquat for cultured mammalian cells. J Biol Chem (1988) 263:1910-1914.
21. Ho YS, Vincent R, Dey MS, Slot JW, Crapo JD: Transgenic models for the study of lung antioxidant defense: Enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia. Am J Respir Cell Mol Biol (1998) 18:538-547.
22. Sohal RS, Agarwal A, Agarwal S, Orr WC: Simultaneous overexpression of copper- and zinc-containing superoxide dismutase and catalase retards age-related oxidative damage and increases metabolic potential in Drosophilia melanogaster. J Biol Chem (1995) 270:15671-15674.
23. Halliwell B, Gutteridge JMC (Eds): Free Radicals in Biology and Medicine. Oxford University Press, Oxford, UK (1989).
24. Maxwell SRJ: Prospects for the use of antioxidant therapies. Drugs (1995) 49:345-361.
25. McCord JM: Free radicals and inflammation: Protection of synovial fluid by superoxide dismutase. Science (1974) 185:529-531.
26. Werns SW: Sustained limitation by superoxide dismutase of canine myocardial injury due to ischemia followed by reperfusion. J Cardiovasc Pharmacol (1988) 11:36-44.
27. Omar BA, McCord JM: Interstitial equilibration of superoxide dismutase correlates with it protective effect in the isolated rabbit heart. J Mol Cell Cardiol (1991) 23:149-159.
28. McCord JM: Superoxide dismutase: Rationale for use in reperfusion injury and inflammation. J Free Rad Biol Med (1986) 2:307-310.
29. Burton KP: Superoxide dismutase enhances recovery following myocardial ischemia. Am J Physiol (1985) 248:H637-H64.
30. Hangaishi M, Nakajima H, Taguchi J, Igarashi R, Hoshino J, Kurokawa K, Kimura S, Nagai R, Ohno M: Lecithinized Cu, Zn-superoxide dismutase limits the infarct size following ischemia-reperfusion injury in rat hearts in vivo. Biochem Biophys Res Commun (2001) 285:1220-1225.
31. Li Q, Bolli R, Qui Y, Tang XL, Guo Y, French BA: Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation (2001) 103:1893-1898. Extracellular superoxide dismutase was highly cardioprotective in rabbits and significantly reduced infarct size compared to controls.
32. Ma XL, Johnson G III, Lefer AM: Low doses of superoxide dismutase and a stable prostacyclin analogue protect in myocardial ischemia and reperfusion. J Am Coll Cardiol (1992) 19:197-204.
33. Chen Z, Oberley TD, Ho Y, Chua CC, Siu B, Hamdy RC, Epstein CJ, Chua BH: Overexpression of CuZnSOD in coronary vascular cells attenuates myocardial ischemia/reperfusion injury. Free Radic Biol Med (2000) 29:589-596.
34. Chen Z, Siu B, Ho YS, Vincent R, Chua CC, Hamdy RC, Chua BH: Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J Mol Cell Cardiol (1998) 30:2281-2289.
35. Zweier JL: Prevention of reperfusion-induced, free radical-mediated acute endothelial injury by super oxide dismutase as an effective tool to delay/prevent chronic renal allograft failure: A review. Transplant Proc (1997) 29:2567-2568.
36. Shingu M, Takahashi S, Ito M, Hamamatu N, Suenaga Y, Ichibangase Y: Anti-inflammatory effects of recombinant human manganese superoxide dismutase on adjuvant arthritis in rats. Rheumatol Int (1994) 14:77-81.
37. Oyanagui Y: Participation of superoxide anions at the prostaglandin phase of carrageenan foot-oedema. Biochem Pharmacol (1976) 25:1465-1472.
38. Klivenyi P, St. Clair D, Wermer M, Yen HC, Oberley T, Yang L, Flint Beal M: Manganese superoxide dismutase overexpression attenuates MPTP toxicity. Neurobiol Dis (1998) 5:253-258.
39. Bravard A, Sabatier L, Hoffschir F, Ricoul M, Luccioni C, Dutrillaux B. SOD2: A new type of tumor-suppressor gene? Int J Cancer (1992) 51:476-480.
40. Church SL, Grant JW, Ridenour LA, Oberley LW, Swanson PE, Meltzer PS: Increased manganese superoxide dismutase expression suppresses the malignant human melanoma cells. Proc Natl Acad Sci USA (1993) 90:3113-3117.
41. St. Clair DK, Oberley TD, Muse KE, St Clair WH: Expression of manganese superoxide dismutase promotes cellular differentiation. Free Radical Biol Med (1994) 16:275-282.
42. Safford SE, Oberley TD, Urano M, St. Clair DK: Suppression of fibrosarcoma metastasis by elevated expression of manganese dismutase. Cancer Res (1994) 54:4261-4265.
43. Yoshizaki N, Mogi Y, Muramatsu H, Koike K, Kogawa K, Niitsu Y: Suppressive effect of recombinant human Cu,Zn-superoxide dismutase on lung metastasis of murine tumor cells. Int J Cancer (1994) 57:287-292.
44. Flores SC, Marecki JC, Harper KP, Bose SK, Nelson SK, McCord JM: Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc Natl Acad Sci USA (1993) 90:7632-7636.
45. Edas MA, Emerit I, Khalhoun Y, Lazizi Y, Cernjavski L, Levy A: Clastogenic factors in plasma of HIV-1 infected patients activate HIV-1 replication in vitro: Inhibition by superoxide dismutase. Free Rad Biol Med (1997) 23:571-578.
46. Mollace V, Nottet HS, Clayette P, Turco MC, Muscoli C, Salvemini D, Perno CF: Oxidative stress and neuroAIDS: Triggers, modulators and novel antioxidants. Trends Neurosci (2001) 24:411-416.
47. Saminen U, Harjula AL, Maasilta PK, Romanska HM, Bishop AE, Polak JM: Superoxide dismutase in development of obliterative bronchiolitis. Transplant Proc (2001) 33:2477
48. Barnes JP: Chronic obstructive pulmonary disease. N Engl J Med (2000) 343:269-280.
49. Wengenack TM, Curran GL, Poduslo JF: Postischemic, systemic administration of polyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia. Brain Res (1997) 754:46-54.
50. Przedborski S, Kostic V, Jackson-Lewis V, Naini AB, Simonetti S, Fahn S, Carlson E, Epstein CJ, Cadet JL: Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J Neurosci (1992) 12:1658-1667.
51. Flohe L: Superoxide dismutase for therapeutic use: Clinical experience, dead ends and hopes. Mol Cell Biochem (1998) 84:123-131.
52. Babior BM: Superoxide: A two-edged sword. J Med Biol Res (1982) 30:141-155.
53. Menander-Huber KB, Edsmyr F, Huber W: Orgotein (superoxide dismutase): A drug for the amelioration of radiation-induced side effects. A double-blind, placebo-controlled study in patients with bladder tumours. Urol Res (1978) 6:255-257.
54. Riley DP, Henke SL, Lennon PJ, Weiss RH, Neumann WL, Rivers WJ, Aston KW, Sample KR, Rahman H, Ling CS, Shieh JL, Busch DH, Szulbinski W: Synthesis, characterization and stability of manganese(II) C-substituted 1,4,7,10,13,pentaazacyclopentadecane complexes exhibitin superoxide dismutase activity. Inorg Chem (1996) 35:5213-5231.
55. Aston K, Rath N, Naik A, Slomczynska U, Schall OF, Riley DP: Computer-aided design (CAD) of Mn(II) complexes: Superoxide dismutase mimetics with catalytic activity exceeding the native enzyme. Inorg Chem (2001) 40:1779-1789.
56. Henke SL: Superoxide dismutase mimics as future therapeutics. Exp Opin Ther Patents (1999) 9:169-180.
57. Lefer AM: Physiologic and pathophysiologic role of cyclo-oxygenase metabolites of arachidonic acid in circulatory disease states. Cardiovasc Clin (1987) 18:85-99.
58. Lefer AM, Tsao PS, Lefer DJ, Ma XL: Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J (1991) 5:2029-2034. After ischemia and reperfusion there is a reduced release of EDRF, which leads to endothelial dysfunction. If administered prior to reperfusion, SOD can preserve endothelial function and protect against myocardial injury.
59. McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med (1985) 312:159-163.
60. Lefer AM, Lefer DJ: Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Ann Rev Pharmacol Toxicol (1993) 33:71-90.
61. Bittermann H, Lefer AM: Use of a novel peptide leukotriene receptor antagonist, LY-163441, in splanchnic artery occlusion shock. Prostaglandins Leukot Essent Fatty Acids (1988) 32:63-68.
62. Bittermann H, Kinarty A, Lazarovich H, Lahat N: Acute release of cytokines is proportional to tissue injury induced by surgical trauma and shock in rats. J Clin Immunol (1991) 11:184-192.
63. Zingarelli B, Squadrito F, Ioculano MP, Altavilla D, Bussolino F, Campo GM, Caputi AP: Platelet activating factor in splanchnic artery occlusion shock. Eur J Pharmacol (1992) 222:13-19.
64. Radomski MW, Palmer RM, Moncada S: An L-arginine/nitric oxide pathway present in human platelets regulates aggreation. Proc Natl Acad Sci USA (1990) 87:5193-5197.
65. Moncada S, Palmer RM, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev (1991) 43:109-142.
66. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 288:373-376.
67. Kubes P, McCafferty DM: Nitric oxide and intestinal inflammation. Am J Med (2000) 109:150-158.
68. Kanwar S, Kubes P: Nitric oxide is an antiadhesive molecule for leukocytes. New Horiz (1995) 3:93-104.
69. Hickey MJ, Kubes P: Role of nitric oxide in regulation of leucocyte-endothelial cell interactions. Exp Physiol (1997) 82:339-348.
70. Buchwalow IB, Podzuweit T, Bocker W, Samoilova VE, Thomas S, Wellner M, Baba HA, Robenek H, Schnekenburger J, Lerch MM: Vascular smooth muscle and nitric oxide synthase. FASEB J (2002) 16:500-508.
71. Tanner FC, Meier P, Greutert H, Champion C, Nabel EG, Luscher TF: Nitric oxide modulates expression of cell cycle regulatory proteins: A cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation (2000) 101:1982-1989.
72. Alderton WK, Cooper CE, Knowles RG: Nitric oxide synthases: Structures, function and inhibition. Biochem J (2001) 357:593-615.
73. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P: Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA (1993) 90:7240-7244.
74. Davidge ST, Baker PN, McLaughlin MK, Roberts JM: Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res (1995) 77:274-283.
75. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA (1990) 87:1620-1624.
76. Ischiropoulos H, Zhu L, Chen J, Tsai M, Martin JC, Smith CD, Beckman JS: Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys (1992) 298:431-437.
77. Beckman JS, Crow JP: Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans (1993) 21:330-334.
78. Crow JP, Beckman JS: Reactions between nitric oxide, superoxide, and peroxynitrite: Footprints of peroxynitrite in vivo. Adv Pharmacol (1995) 34:17-43.
79. Salvemini D, Jensen MP, Riley DP, Misko TP: Therapeutic manipulations of peroxynitrite. Drug News Perspect (1998) 11:204-214.
80. Matheis G, Sherman MP, Buckberg GD, Haybron DM, Young HH, Ignarro LJ: Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol (1992) 262:H616-H620.
81. Schulz R, Wambolt R: Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury. Cardiovasc Res (1995) 30:432-439. Inhibition of NO synthesis after ischemia-reperfusion injury may give more protection than stimulation of NO. This may be due to peroxynitrite formation occurring during reperfusion.
82. Naseem SA, Kontos MC, Rao PS, Jesse RL, Hess ML, Kukreja RC: Sustained inhibition of nitric oxide by NG-nitro-L-arginine improves myocardial function following ischemia/reperfusion in isolated perfused rat heart. J Mol Cell Cardiol (1995) 27:419-426.
83. Wang P, Zweier JL: Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem (1996) 271:29223-29230.
84. Ma TT, Ischiropoulos H, Brass CA: Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion. Gastroenterology (1995) 108:463-469.
85. Yu L, Gengaro PE, Niederberger M, Burke TJ, Schrier RW: Nitric oxide: A mediator in rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci USA (1994) 91:1691-1695.
86. Cuzzocrea S, Zingarelli B, Costantino G, Szabó A, Salzman AL, Caputi AP, Szabó C: Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br J Pharmacol (1997) 121:1065-1074.
87. Szabo C, Salzman AL, Ischiropoulos H: Peroxynitrite-mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury. FEBS Lett (1995) 372:229-232.
88. Fagni L, Lafon-Cazal M, Rondouin G, Manzoni O, Lerner-Natoli M, Bockaert J: The role of free radicals in NMDA-dependent neurotoxicity. Prog Brain Res (1994) 103:381-390.
89. Cazevieille C, Muller A, Meynier F, Bonne C: Superoxide and nitric oxide cooperation in hypoxia/reoxigenation-induced neuron injury. Free Radic Biol Med (1993) 14:389-395.
90. Gunasekar PG, Kanthasamy AG, Borowitz JL, Isom GE: NMDA receptor activation produces concurrent generation of nitric oxide and reactive oxygen species: Implication for cell death. J Neurochem (1995) 65:2016-2021.
91. Ischiropoulos H, Al-Mehdi AB, Fisher AB: Reactive species in ischemic rat lung injury: Contribution of peroxynitrite. Am J Physiol (1995) 269:L158-164.
92. Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS: Evidence for in vivo peroxynitrite production in human acute lunge injury. Am J Respir Crit Care Med (1995) 151:1250-1254.
93. Stern MK, Jensen MP, Kramer K: Peroxynitrite decomposition catalysts. J Am Chem Soc (1996) 118:8735-8736.
94. Naseem SA, Kontos MC, Rao PS, Jesse RL, Hess ML, Kukreja RC: Sustained inhibition of nitric oxide by NG-nitro-L-arginine improves myocardial function following ischemia/reperfusion in isolated perfused rat heart. J Mol Cell Cardiol (1995) 27:419-426.
95. Ferdinandy P, Danial H, Ambrus I, Rothery RA, Schulz R: Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res (2000) 87:241-247.
96. Cuzzocrea S, Misko TP, Costantino G, Mazzon E, Micali A, Caputi AP, Macarthur H, Salvemini D: Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnicv artery occlusion and reperfusion. FASEB J (2000) 14:1061-1072.
97. Hardy MM, Flickinger AG, Riley DP, Weiss RH, Ryan US: Superoxide dismutase mimetics inhibit neutrophil-mediated human aortic endothelial cell injury in vitro. J Biol Chem (1994) 269;18535-18540.
98. Okayama N, Grisham MB, Kevil CG, Eppihimer LA, Wink DA, Alexander JS: Effect of reactive oxygen metabolites on endothelial permeability: Role of nitric oxide and iron. Microcirculation (1999) 6:107-116.
99. Tanita T, Song C, Kubo H, Hoshikawa Y, Chida M, Suzuki S, Ono S, Fujimura S: Superoxide anion mediates pulmonary vascular permeability caused by neutrophils in cardiopulmonary bypass. Surg Today (1999) 29:755-761.
100. Koo DD, Welsh KI, West NE, Channon KM, Penington AJ, Roake JA, Morris PJ, Fuggle SV: Endothelial cell protection against ischemia/reperfusion injury by lecithinized superoxide dismutase. Kidney Int (2001) 60:786-796.
101. Fantone JC, Ward PA: Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol (1982) 107:395-418.
102. Deitch EA, Bridges W, Berg R, Specian RD, Granger DN: Hemorrhagic shock-induced bacterial translocation: The role of neutrophils and hydroxyl radicals. J Trauma (1990) 30:942-951.
103. Boughton-Smith NK, Evans SM, Laszlo F, Whittle BJ, Moncada S: The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol (1993) 110:1189-1195.
104. Salvemini D, Wang ZQ, Wyatt PS, Bourdon DM, Marino MH, Manning PT, Currie MG: Nitric oxide: A key mediator in the early and late phase of carrageenan- induced rat paw inflammation. Br J Pharmacol (1996) 118:829-838.
105. Mannaioni PF, Masini E: The release of histamine by free radicals. Free Radic Biol Med (1988) 5:177-197.
106. Dix TA, Hess KM, Medina MA, Sullivan RW, Tilly SL, Webb TL: Mechanism of site-selective DNA nicking by the hydrodioxyl (perphydroxyl) radical. Biochemistry (1996) 35:4578-4583.
107. Butcher EC: Specificity of leukocyte-endothelial interactions and diapedesis: Physiologic and therapeutic implications of an active decision process. Res Immunol (1993) 144:695-698.
108. Geng JG, Bevilacqua MP, Moore KL, McIntyre TM, Prescott SM, Kim JM, Bliss GA, Zimmerman GA, McEver RP: Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature (1990) 343:757-760.
109. Von Andrian UH, Chambers JD, McEvoy LM, Bargatze RF, Arfors KE, Butcher EC: Two-step model of leukocyte-endothelial cell interaction in inflammation: Distinct roles for LECAM-1 and the leukocyte β2 integrins in vivo. Proc Natl Acad Sci USA (1991) 88:7538-7542.
110. Butcher EC: Leukocyte-endothelial cell adhesion as an active, multi-step process: A combinatorial mechanism for specificity and diversity in leukocyte targeting. Adv Exp Med Biol (1992) 323:181-194.
111. Lawrence MB, Springer TA: Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins. Cell (1991) 65:859-873.
112. Boyd AW, Wawryk SO, Burns GF, Fecondo JV: Intercellular adhesion molecule-1 (ICAM-1) has a central role in cell-cell contract-mediated immune mechanism. Proc Natl Acad Sci USA (1988) 85:3095-3099.
113. Kanwar S, Tepperman BL, Payne D, Sutherland LR, Kubes P: Time course of nitric oxide production and epithelial dysfunction during ischemia/reperfusion of the feline small intestine. Circ Shock (1994) 42:135-140.
114. Gryglewski RJ, Swies J: Cardioprotection by molsidomine and iloprost in myocardial ischemia in anaesthetized cats. Agents Actions Suppl (1992) 37:265-272.
115. Masini E, Bianchi S, Mugnai L, Gambassi F, Lupini M, Pistelli A, Mannaioni PF: The effect of nitric oxide generators on ischemia reperfusion injury and histamine release in isolated perfused guinea-pig heart. Agents Actions (1991) 33:53-56.
116. Carey C, Siegfried MR, Ma XL, Weyrich AS, Lefer AM: Antishock and endothelial protective actions of a NO donor in mesenteric ischemia and reperfusion. Circ Shock (1992) 38:209-216.
117. Mannaioni PF, Masini E, Pistelli A, Salvemini D, Vane JR: Mast cells as a source of superoxide anions and nitric oxide-like factor: Relevance to histamine release. Int J Tiss Reac (1991) 13:271-278.
118. Keller AM, Clancy RM, Barr ML, Marboe CC, Cannon PJ: Acute reoxygenation injury in the isolated rat heart: Role of resident cardiac mast cells. Circ Res (1988) 63:1044-1052.
119. Masini E, Bianchi S, Gambassi F, Palmerani B, Pistelli A, Carlomagno L, Mannaioni PF: Ischemia reperfusion injury and histamine release in isolated and perfused guinea-pig heart: Pharmacological interventions. Agents Actions (1990) 30:198-201.
120. Clark WM, Lauten JD, Lessov N, Woodward W, Coull BM: Time course of ICAM-1 expression and leukocyte subset infiltration in rat forebrain ischemia. Mol Chem Neuropathol (1995) 26:213-230. Following reversible forebrain ischemia, ICAM-1 expression begins at 1 h.
121. Cuzzocrea S, Mazzon E, Dugo L, Caputi AP, Aston K, Riley DP, Salvemini D: Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion. Br J Pharmacol (2001) 132;19-29.
122. Baudry M, Etienne S, Bruce A, Palucki M, Jacobsen E, Malfroy B: Salen-manganese complexes are superoxide dismutase-mimics. Biochem Biophys Res Commun (1993) 192:964-968.
123. Doctrow SR, Huffman K, Marcus CB, Musleh W, Bruce A, Baudry M, Malfroy B: Salen-manganese complexes: Combined superoxide dismutase/catalase mimics with broad pharmacological efficacy. Adv Pharmacol (1997) 38:247-269.
124. Malfroy B, Doctrow SR, Orr PL, Tocco G, Fedoseyeva EV, Benichou G: Prevention and suppression of autoimmune encephalomyelitis by EUK-8, a synthetic catalytic scavenger of oxygen-reactive metabolites. Cell Immunol (1997) 177:62-68.
125. Baker K, Marcus CB, Huffman K, Kruk H, Malfroy B, Doctrow SR: Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: A key role for reactive oxygen species in ischemic injury. J Pharmacol Exp Ther (1998) 284:215-221.
126. Bianca R, Wayman N, McDonald M, Pinto A, Shape M, Chatterjee P, Thiemermann C: Superoxide dismutase mimetic with catalase activity, EUK-134, attenuates the multiple organ injury and dysfunction caused by endotoxin in the rat. Med Sci Monit (2002) 8:BR1-7.
127. Patel M, Day BJ: Metalloporphyrin class of therapeutic catalytic antioxidants. Trends Pharm Sci (1999) 20:359-364.
128. Salvemini D, Mazzon E, Dugo L, Serraino I, De Sarro A, Caputi AP, Cuzzocrea S: Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic. Arthritis Rheum (2001) 44:2909-2922. M-40403-attenuated tissue damage, bone damage and the extent of chronic inflammation, suggesting that SOD mimetics might be useful in treating chronic inflammatory diseases.
129. Salvemini D, Mazzon E, Dugo L, Riley DP, Serraino I, Caputi AP, Cuzzocrea S: Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403. Br J Pharmacol (2001) 13:815-827.
130. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D: Antioxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev (2001) 53:135-159.
131. Cuzzocrea S, Mazzon E, Dugo L, Caputi AP, Riley DP, Salvemini D: Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis. Eur J Pharmacol (2001) 432:79-89.
132. Masini E, Cuzzocrea S, Mazzon E, Marzocco C, Mannaioni PF, Salvemini D: Protective effects of M40403, a selective superoxide dismutase mimetic, in myocardial ischaemia and reperfusion injury in vivo. Br J Pharmacol (2002) in press.
133. Gryglewski RJ, Palmer RM, Moncada S: Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature (1986) 320:454-456.
134. Salvemini D, Wang ZQ, Boudon DM, Stern MK, Currie MG, Manning PT: Evidence of peroxynitrite involvement in the carrageenan-induced rat paw edema. Eur J Pharmacol (1996) 303:217-220.
135. Beckman JS: Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol (1996) 9:836-844.
136. Kooy NW, Lewis SJ, Royall JA, Ye YZ, Kelly DR, Beckman JS Extensive tyrosine nitration in human myocardial inflammation: Evidence for the presence of peroxynitrite. Crit Care Med (1997) 25:812-819.
137. Mihm J, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, Bauer JA: Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation (2001) 104:174-180.
138. Mihm MJ, Coyle CM, Schanbacher BL, Weinstein DM, Bauer JA: Peroxynitrite induce nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovasc Res (2001) 49:798-807.
139. Inoue S, Kawanishi S: Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Lett (1995) 371:86-88.
140. Salgo MG, Bermudez E, Squadrito G, Pryor W: Peroxynitrite causes DNA damage and oxidation of thiols in rat thymocytes. Arch Biochem Biophys (1995) 322:500-505.
141. Szabó C, Dawson VL: Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci (1999) 19:287-298.
142. Cuzzocrea S, Zingarelli B, Gilard E, Hake P, Salzman AL, Szabó C: Protective effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthase in carrageenan-induced models of local inflammation. Eur J Pharmacol (1998) 342:67-76.
143. Szabó C, Lim LH, Cuzzocrea S, Getting SJ, Zingarelli, Flower RJ, Salzman AL, Perretti M: Inhibition of poly (ADP-ribose) synthetase exerts anti-inflammatory effects and inhibits neutrophil recruitment. J Exp Med (1997) 186:1041-1049.
144. Szabo G, Bahrle S, Stumpf N, Sonnenberg K, Szabo EE, Pacher P, Csont T, Schulz R, Dengler TJ, Liaudet L, Jagtap PG, Southan GJ, Vahl CF, Hagl S, Szabo C: Poly(ADP-ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res (2002) 90:100-106.
145. Wayman N, McDonald MC, Thompson AS, Threadgill MD, Thiemermann C: 5-aminoisoquinolinone, a potent inhibitor of poly (adenosine 5′-diphosphate ribose) polymerase, reduces myocardial infarct size. Eur J Pharmacol (2001) 430:93-100.
146. Thiemermann C: Inhibition of the activity of poly (ADP-ribose) polymerase in ischemia-reperfusion injury. Shock (2000) 14:142-143.
147. Zingarelli B, Salzman AL, Szabo C: Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ Res (1998) 83:85-94.
148. - in neutrophil recruitment into sites of dermal and pulmonary vasculitis. Free Radic Biol Med (1990) 8:163-172.
149. Al-Shabanah OA, Mansour MA, Elmazar MM: Enhanced generation of leukotriene B4 and superoxide radical from calcium ionophore (A23187) stimulated human neutrophils after priming with interferon-α. Res Commun Mol Pathol Pharmacol (1999) 106:115-128.
150. Salvemini D, Wang ZQ, Wyatt PS, Bourdon D, Marino MH, Manning PT, Currie MG: Nitric oxide: A key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br J Pharmacol (1996) 118:829-838.
151. Dreyer WJ, Michael LH, West MS, Smith CW, Rothlein R, Rossen RD, Anderson DC, Entman ML: Neutrophil accumulation in ischemic canine myocardium. Insights into time course, distribution, and mechanism of localization during early reperfusion. Circulation (1991) 84:400-411.
152. Farhood A, McGuire GM, Manning AM, Miyasaka M, Smith CW, Jaeschke H: Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver. J Leukocyte Biol (1995) 57:368-374.
153. Shreeniwas R, Koga S, Karakurum M, Pinsky D, Kaiser E, Brett J, Wolitzky BA, Norton C, Plocinski J, Benjamin W et al: Hypoxia-mediated induction of endothelial cell interleukin-1α. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J Clin Invest (1992) 90:2333-2339.
154. 2+. Inflamm Res (1999) 48:544-549. In isolated human mononuclear cells, the production of superoxide caused an increase in TNFα synthesis; Monocytes were responsible for producing this elevated TNFα.
155. Matata BM, Galinanes M: Peroxynitrite is an essential component of cytokine production mechanism in human monocytes through modulation of NF-κB DNA-binding activity. J Biol Chem (2002) 277:2330-2335.